You are currently viewing House Dems to Senate leadership: Quickly move a reconciliation bill with drug price negotiation reforms

House Dems to Senate leadership: Quickly move a reconciliation bill with drug price negotiation reforms

Twenty House Democrats, including Reps. Katie Porter of California and Susan Wild of Pennsylvania, are calling on Senate leaders to move quickly with a reconciliation bill (meaning they only need a simple majority for passage) with prescription drug pricing reforms, and to include adding new authority for Medicare to negotiate drug prices.

They also called on the Senate to specifically follow suit with the House passage of a $35 per month insulin cap (as Senate Majority Leader Chuck Schumer’s deadline for a vote on that provision has come and gone), and to cap Medicare Part D costs at $2,000 per year for seniors.

“We represent the most competitive districts in Congress,” they wrote to Schumer and Sen. Ron Wyden (D-OR). “Just like you, we were sent to Washington on the promise that we’d tackle big issues and work to improve the lives of those we represent. And what issue do we hear about at every town hall? At every event? The price of prescription drugs.”’With the 50-50 Senate party-line split, Dems will need every last vote to even pass a reconciliation bill. Previously, they didn’t muster the support in the now-failed Build Back Better Act, which included some of these same drug pricing provisions, but was ultimately upended by Sen. Joe Manchin (D-WV) for reasons unrelated to drug pricing.

“We’ve promised to take on Big Pharma’s price gouging for years,” the House Democrats wrote in their letter dated Thursday. “Let’s make good on this promise. We have the votes and, more importantly, we have the backing of the American people — Democrats, Republicans, and independents.”